It has been reported that multiple PPARγ agonists can upregulate PTEN expression in many types of cancer cells including human osteosarcoma cells, hepatoma carcinoma cells, and lung adenocarcinoma cells (Ni et al. 2017; Zhang et al. 2006). This evidence concerns the gene PPARG and lung adenocarcinoma.